COMPANY NAME
AorTech International plc
Incorporated in Scotland, Company Registration number SC170071
AorTech Biomaterials Pty Limited
A wholly owned subsidiary of AorTech International plc incorporated and operating in Australia.
AorTech Medical Devices Inc., USA
A wholly owned subsidiary of AorTech International plc incorporated and operating in the United States.
ACTING CHIEF FINANACIAL OFFICER
Eddie McDaid, Chartered Accountant
COMPANY SECRETARY
David Parsons ACIS
REGISTERED OFFICE
2 Blythswood Square, Glasgow, G2 4AD
HEAD OFFICE
864 Diestel Road, Salt Lake City, Utah 84105, USA
REGISTERED AUDITORS
Grant Thornton UK LLP, Regent House, 80 Regent Road, Leicester LE1 7NH (appointed 20 January 2006)
NOMINATED ADVISORS & BROKERS
Evolution Securities Limited, 100 Wood Street, London EC2V 7AN (appointed 13 April 2006)
SOLICITORS
Brodies LLP Solicitors 2 Blythswood Square, Glasgow, G2 4AD
BANKERS
Bank of Scotland, 123 St. Vincent Street, Glasgow G2 5EA
Westpac, 425 Victoria Avenue, Chatswood NSW 2067, Australia
REGISTRARS
Equniti Registrars Scotland, 1st Floor, 34 South Gyle Crescent, South Gyle Business Park, Edinburgh EH12 9EB
Shareholder helpline: 0870 6015366
Shareholder website:
SHARES ON ISSUE
4,832,778
SIGNIFICANT SHAREHOLDERS:
Disclosure of this information is in accordance with rule 26 of the AIM listing requirements
Significant shareholders in the Company (those holding in excess of 3% of the total issued shares) as of 17 April 2010 comprised:
F&C Asset Management 18.45%
Gartmore Investment Management 5.55%
Walker Crips Stockbrokers 4.55%
Barclays Wealth 4.53%
M D Barnard & Co 3.78%
Williams de Broe 3.50%
Percentage of Shares not in public hands (32.3%)*